Concept explainers
Arsenic is a known carcinogen and poison. The standard laboratory procedures for measuring arsenic concentration (mg/L) in water are expensive. Consider the accompanying summary data and Minitab output for comparing a laboratory method to a new relatively quick and inexpensive field method (from the article “Evaluation of a New Field Measurement Method for Arsenic in Drinking Water Samples,” J. of Envir. Engr., 2008: 382–388).
Two-Sample T-Test and CI
Sample | N | Mean | StDev | SE Mean |
1 | 3 | 19. 70 | 1.10 | 0 . 64 |
2 | 3 | 10 . 90 | 0 . 60 | 0 .35 |
Estimate for difference: 8.800 | ||||
95% Cl for difference: (6.498, 11.102) | ||||
T-Test of difference = 0 (vs not =) : | ||||
T-Value =12.16 P-Value =0.001 DF = 3 |
What conclusion do you draw about the two methods, and why? Interpret the given confidence interval. [Note: One of the article’s authors indicated in private communication that they were unsure why the two methods disagreed.]
Trending nowThis is a popular solution!
Chapter 9 Solutions
Probability and Statistics for Engineering and the Sciences
- The article “Treadmill Exercise and Resistance Training in Patients With Peripheral Arterial Disease With and Without Intermittent Claudication. A Randomized Controlled Trial” (M. McDermott, P. Ades, et al., Journal of the American Medical Association, 2009:165–174) reported the results of a study to determine whether treadmill exercise could improve the walking ability of patients suffering from claudication, which is pain caused by insufficient blood flow to the muscles of the legs. A sample of 48 patients walked on a treadmill for six minutes every day. After six months, the mean distance walked in six minutes was 348 m, with a standard deviation of 80 m. For a control group of 46 patients who did not walk on a treadmill, the mean distance was 309 m with a standard deviation of 89 m. Find a 95% confidence interval for the difference in mean distance walked between the two groups of patients.arrow_forwardThe article “Treadmill Exercise and Resistance Training in Patients With Peripheral Arterial Disease With and Without Intermittent Claudication. A Randomized Controlled Trial” (M. McDermott, P. Ades, et al., Journal of the American Medical Association, 2009:165–174) reported the results of a study to determine whether treadmill exercise could improve the walking ability of patients suffering from claudication, which is pain caused by insufficient blood flow to the muscles of the legs. A sample of 48 patients walked on a treadmill for six minutes every day. After six months, the mean distance walked in six minutes was 348 meters, with a standard deviation of 80 m. For a control group of 46 patients who did not walk on a treadmill, the mean distance was 309 m with a standard deviation of 89 m. Can you conclude that the mean distance walked for patients using a treadmill is greater than the mean for the controls? Use the α = 0.05 level of significance.arrow_forwardA new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 2 2 4 6 New Drug 1 2 2 3 7 Old Drug New Drug Total Sample (Ordered Smallest to Largest) Ranks Old Drug New Drug Old Drug New Drug 1 1 1 1 1.5 1.5 2 2 2 2 4.5 4.5 2 2 2 2 4.5 4.5 4 3 3 7 6 7 4 8 6…arrow_forward
- A new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 3 3 4 6 New Drug 1 2 3 3 7arrow_forwardA new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by PatientsOld Drug 1 2 2 4 6 New Drug 1 2 2 3 7Old Drug New Drug Total Sample(Ordered Smallest to Largest) RanksOld Drug New Drug Old Drug New DrugR1= R2= A) We reject H0 in favor of H1, which states the two populations are not equal at the alpha equals .05 level because the calculated U value of 12.5 is greater than the critical U value of 2.B) We reject H0 in favor of H1, which states the two populations are not equal at the alpha equals .05…arrow_forwardA new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 3 3 4 6 New Drug 1 2 3 3 7 Old Drug New Drug Total Sample (Ordered Smallest to Largest) Ranks Old Drug New Drug Old Drug New Drug…arrow_forward
- A new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 3 3 4 6 New Drug 1 2 3 3 7 Old Drug New Drug Total Sample (Ordered Smallest to Largest) Ranks Old Drug New Drug Old Drug New Drug…arrow_forwardA new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 2 2 4 6 New Drug 1 2 2 3 7 Old Drug New Drug Total Sample (Ordered Smallest to Largest) Ranks Old Drug New Drug Old Drug New Drug 1 1 1 1 1.5 1.5 2 2 2 2 4.5 4.5 2 2 2 2 4.5 4.5 4 3 3 7 6 7 4 8 6…arrow_forwardA new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05. Pain Rating as Reported by Patients Old Drug 1 3 3 4 6 New Drug 1 2 3 3 7 A) We fail to reject H0, which states the two populations are equal at the alpha equals .05 level because the calculated Uvalue of 10.5 is greater than the critical U value of 2. B) We fail to reject H0, which states the two populations are equal at the alpha equals .05 level…arrow_forward
- In a clinical trial of the effectiveness of echinacea for preventing colds, the results in the table below were obtained. Use a 0.05 significance level to test the claim that getting a cold is independent of the treatment group. What do the results suggest about the effectiveness of echinacea as a prevention against colds? Can we conclude that the prevention against colds relies on the use of echinacea? Treatment Group Placebo Echinacea: 20% extract Echinacea: 60% extract Got a Cold 82 45 41 Did Not Get a Cold 11 2 9 Round to four decimal places if necessary. a) Write the hypotheses b) The expected frequency of people who used 20% extract of Echinacea and got a cold is . The expected frequency of people who used 40% extract of Echinacea and did not get a cold is . c) significance level: α = d) Test statistic: e) Compute p-value of the test statistic. f) Decision: g) Write conclusionarrow_forwardIs Seat Belt Use Independent of Cigarette Smoking?A study of seat belt users and nonusers yielded the randomly selected sample data summarized in the given table (based on data from “What Kinds of People Do Not Use Seat Belts?” by Helsing and Comstock,American Journal of Public Health,Vol. 67, No. 11). Test the claim that the amount of smoking is independent of seat belt use. A plausible theory is that people who smoke more are less concerned about their health and safety and are therefore less inclined to wear seat belts. Is this theory supported by the sample data?arrow_forwardThe article “Capillary Leak Syndrome in Children with C4A-Deficiency Undergoing Cardiac Surgery with Cardiopulmonary Bypass: A Double-Blind, Randomised Controlled Study” (S. Zhang, S. Wang, et al., Lancet, 2005:556–562) presents the results of a study of the effectiveness of giving blood plasma containing complement component C4A to pediatric cardiopulmonary bypass patients. Of 58 patients receiving C4A-rich plasma, the average length of hospital stay was 8.5 days and the standard deviation was 1.9 days. Of 58 patients receiving C4A-free plasma, the average length of hospital stay was 11.9 days and the standard deviation was 3.6 days. Can you conclude that the mean hospital stay is shorter for patients receiving C4A-rich plasma?arrow_forward
- MATLAB: An Introduction with ApplicationsStatisticsISBN:9781119256830Author:Amos GilatPublisher:John Wiley & Sons IncProbability and Statistics for Engineering and th...StatisticsISBN:9781305251809Author:Jay L. DevorePublisher:Cengage LearningStatistics for The Behavioral Sciences (MindTap C...StatisticsISBN:9781305504912Author:Frederick J Gravetter, Larry B. WallnauPublisher:Cengage Learning
- Elementary Statistics: Picturing the World (7th E...StatisticsISBN:9780134683416Author:Ron Larson, Betsy FarberPublisher:PEARSONThe Basic Practice of StatisticsStatisticsISBN:9781319042578Author:David S. Moore, William I. Notz, Michael A. FlignerPublisher:W. H. FreemanIntroduction to the Practice of StatisticsStatisticsISBN:9781319013387Author:David S. Moore, George P. McCabe, Bruce A. CraigPublisher:W. H. Freeman